Selected research
Industry Research
Panic Attack Treatment Industry Research Report 2026
Market perspective
The global Panic Attack Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Panic Attack Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Panic Attack Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Panic Attack Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Panic Attack Treatment include Noven Pharmaceuticals, Inc., Recordati Rare Diseases(Recordati), Actavis Generics, Bristol Myers Squibb(BMS), Baxter International Inc., Sumitomo Dainippon Pharma, GlaxoSmithKline plc., Pfizer,Inc. and Eli Lilly and Company, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Panic Attack Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Panic Attack Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Panic Attack Treatment Market by Company
Noven Pharmaceuticals, Inc.
Recordati Rare Diseases(Recordati)
Actavis Generics
Bristol Myers Squibb(BMS)
Baxter International Inc.
Sumitomo Dainippon Pharma
GlaxoSmithKline plc.
Pfizer,Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Shionogi & Co., Ltd.
Panic Attack Treatment Segment by Type
Selective Serotonin Reuptake Inhibitor(SSRI)
Benzodiazepines(BZD)
Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Panic Attack Treatment Segment by Application
Hospitals
Mental Healthcare Centers
Others
Panic Attack Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Panic Attack Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Panic Attack Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Panic Attack Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Panic Attack Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Selective Serotonin Reuptake Inhibitor(SSRI)
- Benzodiazepines(BZD)
- Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Applications
- Hospitals
- Mental Healthcare Centers
- Others
Companies covered
- Noven Pharmaceuticals, Inc.
- Recordati Rare Diseases(Recordati)
- Actavis Generics
- Bristol Myers Squibb(BMS)
- Baxter International Inc.
- Sumitomo Dainippon Pharma
- GlaxoSmithKline plc.
- Pfizer,Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Shionogi & Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Panic Attack Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Selective Serotonin Reuptake Inhibitor(SSRI)
- 2.2.3 Benzodiazepines(BZD)
- 2.2.4 Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
- 2.3 Panic Attack Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Mental Healthcare Centers
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Panic Attack Treatment Breakdown Data by Type
- 3.1 Global Panic Attack Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Panic Attack Treatment Forecasted Market Size by Type (2027-2032)
4 Panic Attack Treatment Breakdown Data by Application
- 4.1 Global Panic Attack Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Panic Attack Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Panic Attack Treatment Market Perspective (2021-2032)
- 5.2 Global Panic Attack Treatment Growth Trends by Region
- 5.2.1 Global Panic Attack Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Panic Attack Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Panic Attack Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Panic Attack Treatment Market Dynamics
- 5.3.1 Panic Attack Treatment Industry Trends
- 5.3.2 Panic Attack Treatment Market Drivers
- 5.3.3 Panic Attack Treatment Market Challenges
- 5.3.4 Panic Attack Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Panic Attack Treatment Players by Revenue
- 6.1.1 Global Top Panic Attack Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Panic Attack Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Panic Attack Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Panic Attack Treatment Head Office and Area Served
- 6.4 Global Panic Attack Treatment Players, Product Type & Application
- 6.5 Global Panic Attack Treatment Manufacturers Established Date
- 6.6 Global Panic Attack Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Panic Attack Treatment Market Size (2021-2032)
- 7.2 North America Panic Attack Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Panic Attack Treatment Market Size by Country (2021-2026)
- 7.4 North America Panic Attack Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Panic Attack Treatment Market Size (2021-2032)
- 8.2 Europe Panic Attack Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Panic Attack Treatment Market Size by Country (2021-2026)
- 8.4 Europe Panic Attack Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Panic Attack Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Panic Attack Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Panic Attack Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Panic Attack Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Panic Attack Treatment Market Size (2021-2032)
- 10.2 South America Panic Attack Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Panic Attack Treatment Market Size by Country (2021-2026)
- 10.4 South America Panic Attack Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Panic Attack Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Panic Attack Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Panic Attack Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Panic Attack Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Noven Pharmaceuticals, Inc.
- 12.1.1 Noven Pharmaceuticals, Inc. Company Information
- 12.1.2 Noven Pharmaceuticals, Inc. Business Overview
- 12.1.3 Noven Pharmaceuticals, Inc. Revenue in Panic Attack Treatment Business (2021-2026)
- 12.1.4 Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio
- 12.1.5 Noven Pharmaceuticals, Inc. Recent Developments
- 12.2 Recordati Rare Diseases(Recordati)
- 12.2.1 Recordati Rare Diseases(Recordati) Company Information
- 12.2.2 Recordati Rare Diseases(Recordati) Business Overview
- 12.2.3 Recordati Rare Diseases(Recordati) Revenue in Panic Attack Treatment Business (2021-2026)
- 12.2.4 Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio
- 12.2.5 Recordati Rare Diseases(Recordati) Recent Developments
- 12.3 Actavis Generics
- 12.3.1 Actavis Generics Company Information
- 12.3.2 Actavis Generics Business Overview
- 12.3.3 Actavis Generics Revenue in Panic Attack Treatment Business (2021-2026)
- 12.3.4 Actavis Generics Panic Attack Treatment Product Portfolio
- 12.3.5 Actavis Generics Recent Developments
- 12.4 Bristol Myers Squibb(BMS)
- 12.4.1 Bristol Myers Squibb(BMS) Company Information
- 12.4.2 Bristol Myers Squibb(BMS) Business Overview
- 12.4.3 Bristol Myers Squibb(BMS) Revenue in Panic Attack Treatment Business (2021-2026)
- 12.4.4 Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio
- 12.4.5 Bristol Myers Squibb(BMS) Recent Developments
- 12.5 Baxter International Inc.
- 12.5.1 Baxter International Inc. Company Information
- 12.5.2 Baxter International Inc. Business Overview
- 12.5.3 Baxter International Inc. Revenue in Panic Attack Treatment Business (2021-2026)
- 12.5.4 Baxter International Inc. Panic Attack Treatment Product Portfolio
- 12.5.5 Baxter International Inc. Recent Developments
- 12.6 Sumitomo Dainippon Pharma
- 12.6.1 Sumitomo Dainippon Pharma Company Information
- 12.6.2 Sumitomo Dainippon Pharma Business Overview
- 12.6.3 Sumitomo Dainippon Pharma Revenue in Panic Attack Treatment Business (2021-2026)
- 12.6.4 Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio
- 12.6.5 Sumitomo Dainippon Pharma Recent Developments
- 12.7 GlaxoSmithKline plc.
- 12.7.1 GlaxoSmithKline plc. Company Information
- 12.7.2 GlaxoSmithKline plc. Business Overview
- 12.7.3 GlaxoSmithKline plc. Revenue in Panic Attack Treatment Business (2021-2026)
- 12.7.4 GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio
- 12.7.5 GlaxoSmithKline plc. Recent Developments
- 12.8 Pfizer,Inc.
- 12.8.1 Pfizer,Inc. Company Information
- 12.8.2 Pfizer,Inc. Business Overview
- 12.8.3 Pfizer,Inc. Revenue in Panic Attack Treatment Business (2021-2026)
- 12.8.4 Pfizer,Inc. Panic Attack Treatment Product Portfolio
- 12.8.5 Pfizer,Inc. Recent Developments
- 12.9 Eli Lilly and Company
- 12.9.1 Eli Lilly and Company Company Information
- 12.9.2 Eli Lilly and Company Business Overview
- 12.9.3 Eli Lilly and Company Revenue in Panic Attack Treatment Business (2021-2026)
- 12.9.4 Eli Lilly and Company Panic Attack Treatment Product Portfolio
- 12.9.5 Eli Lilly and Company Recent Developments
- 12.10 F. Hoffmann-La Roche Ltd
- 12.10.1 F. Hoffmann-La Roche Ltd Company Information
- 12.10.2 F. Hoffmann-La Roche Ltd Business Overview
- 12.10.3 F. Hoffmann-La Roche Ltd Revenue in Panic Attack Treatment Business (2021-2026)
- 12.10.4 F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio
- 12.10.5 F. Hoffmann-La Roche Ltd Recent Developments
- 12.11 Abbott Laboratories
- 12.11.1 Abbott Laboratories Company Information
- 12.11.2 Abbott Laboratories Business Overview
- 12.11.3 Abbott Laboratories Revenue in Panic Attack Treatment Business (2021-2026)
- 12.11.4 Abbott Laboratories Panic Attack Treatment Product Portfolio
- 12.11.5 Abbott Laboratories Recent Developments
- 12.12 Shionogi & Co., Ltd.
- 12.12.1 Shionogi & Co., Ltd. Company Information
- 12.12.2 Shionogi & Co., Ltd. Business Overview
- 12.12.3 Shionogi & Co., Ltd. Revenue in Panic Attack Treatment Business (2021-2026)
- 12.12.4 Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio
- 12.12.5 Shionogi & Co., Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst